Vertex Pharmaceuticals (Brazil) Buy Hold or Sell Recommendation
| VRTX34 Stock | BRL 517.40 2.06 0.40% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Vertex Pharmaceuticals Incorporated is 'Sell'. Macroaxis provides Vertex Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding VRTX34 positions. The advice algorithm takes into account all of Vertex Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Vertex Pharmaceuticals' buy or sell advice are summarized below:
Real Value 486.68 | Hype Value 517.4 | Market Value 517.4 | Naive Value 517.07 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Vertex Pharmaceuticals Incorporated given historical horizon and risk tolerance towards Vertex Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Vertex Pharmaceuticals Incorporated, the advice is generated through an automated system that utilizes algorithms and statistical models.
Vertex |
Execute Vertex Pharmaceuticals Buy or Sell Advice
The Vertex recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Vertex Pharmaceuticals Incorporated. Macroaxis does not own or have any residual interests in Vertex Pharmaceuticals Incorporated or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Vertex Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Vertex Pharmaceuticals Trading Alerts and Improvement Suggestions
| Vertex Pharmaceuticals generated a negative expected return over the last 90 days |
Vertex Pharmaceuticals Returns Distribution Density
The distribution of Vertex Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Vertex Pharmaceuticals' future price movements. The chart of the probability distribution of Vertex Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Vertex Pharmaceuticals Incorporated price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Vertex Pharmaceuticals returns is essential to provide solid investment advice for Vertex Pharmaceuticals.
| Mean Return | -0.0082 | Value At Risk | -2.72 | Potential Upside | 2.80 | Standard Deviation | 1.50 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Vertex Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Vertex Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Vertex Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Vertex Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Vertex stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.02 | |
β | Beta against NYSE Composite | 0.06 | |
σ | Overall volatility | 1.46 | |
Ir | Information ratio | -0.05 |
Vertex Pharmaceuticals Volatility Alert
Vertex Pharmaceuticals Incorporated exhibits very low volatility with skewness of 0.06 and kurtosis of 0.43. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Vertex Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Vertex Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Vertex Pharmaceuticals Fundamentals Vs Peers
Comparing Vertex Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Vertex Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Vertex Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Vertex Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Vertex Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Vertex Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Vertex Pharmaceuticals to competition |
| Fundamentals | Vertex Pharmaceuticals | Peer Average |
| Return On Equity | 0.28 | -0.31 |
| Return On Asset | 0.17 | -0.14 |
| Profit Margin | 0.37 % | (1.27) % |
| Operating Margin | 0.49 % | (5.51) % |
| Current Valuation | 372.17 B | 16.62 B |
| Shares Outstanding | 1.03 B | 571.82 M |
| Price To Earning | 18.08 X | 28.72 X |
| Price To Book | 6.20 X | 9.51 X |
| Price To Sales | 49.16 X | 11.42 X |
| Revenue | 8.93 B | 9.43 B |
| Gross Profit | 7.55 B | 27.38 B |
| EBITDA | 4.29 B | 3.9 B |
| Net Income | 3.32 B | 570.98 M |
| Cash And Equivalents | 6.71 B | 2.7 B |
| Cash Per Share | 6.46 X | 5.01 X |
| Total Debt | 509.8 M | 5.32 B |
| Debt To Equity | 0.1 % | 48.70 % |
| Current Ratio | 4.61 X | 2.16 X |
| Book Value Per Share | 13.53 X | 1.93 K |
| Cash Flow From Operations | 2.64 B | 971.22 M |
| Earnings Per Share | 17.03 X | 3.12 X |
| Price To Earnings To Growth | 0.42 X | 4.89 X |
| Number Of Employees | 4.8 K | 18.84 K |
| Beta | 0.46 | -0.15 |
| Market Capitalization | 403.29 B | 19.03 B |
| Total Asset | 18.15 B | 29.47 B |
| Net Asset | 18.15 B |
Vertex Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Vertex . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 517.4 | |||
| Day Typical Price | 517.4 | |||
| Price Action Indicator | 1.03 | |||
| Period Momentum Indicator | 2.06 |
About Vertex Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Vertex Pharmaceuticals Incorporated? Buying financial instruments such as Vertex Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Vertex Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Realty Funds Thematic Idea Now
Realty Funds
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Realty Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Vertex Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Vertex Stock refer to our How to Trade Vertex Stock guide.Note that the Vertex Pharmaceuticals information on this page should be used as a complementary analysis to other Vertex Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Vertex Stock analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |